SCM
OGN icon

Salem Capital Management’s Organon & Co OGN Stock Holding History

Salem Capital Management’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,751
Closed -$265K – 74
2021
Q2 		$265K Buy
+8,751
New +$288K 0.15% 63

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salem Capital Management's OGN Position: Q3 2021 in Review

Salem Capital Management sold out of Organon & Co (OGN) in Q3 2021, closing a stake of 8,751 shares — an estimated $265K sold.

Salem Capital Management first reported a position in OGN in Q2 2021 and held it in 1 quarter. The position peaked at $265K in Q2 2021. 927 funds tracked by Wall St. Rank hold OGN as of Q3 2021.

  • Salem Capital Management reported no remaining Organon & Co position as of Q3 2021 after selling out during the quarter.
  • Salem Capital Management sold 8,751 Organon & Co shares in Q3 2021, an estimated $265K.
  • Salem Capital Management first reported a position in Organon & Co in Q2 2021 and held it in 1 quarter.
  • Salem Capital Management's Organon & Co position peaked at $265K in Q2 2021.
  • 927 funds tracked by Wall St. Rank held Organon & Co as of Q3 2021.

Based on Salem Capital Management's 13F filing for Q3 2021, filed 12 Oct 2021.